IRF1 gene
Evidence from:
primary |
all sources
Related entities (4)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| interferon gamma | regulates | IRF1 | — | 1 |
| IRF1 | risk_factor_for | anhedonia | — | 1 |
| IRF1 | expressed_in | cocaine use disorder | — | 1 |
| TNF-α | regulates | IRF1 | — | 1 |
Mentioned in (9)
Papers in which this entity is mentioned.
- Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors. (2023)
- Chronic oligodendrocyte injury in central nervous system pathologies. (2022)
- Genetics of substance use disorders in the era of big data. (2021)
- The Immune Landscape of Cancer. (2018)
- Genetic effects on gene expression across human tissues. (2017)
- Recurrent somatic mutations in regulatory regions of human cancer genomes. (2015)
- DNA methylation contributes to natural human variation. (2013)
- Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. (2012)
- The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cycles. (2009)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| irf1 | gene | 9 | 11 |
| irf-1 | gene | 1 | 1 |
| interferon regulatory factor 1 | gene | — | — |